Antibody-Cytokine Fusion Proteins: Harnessing the Combined Power of Cytokines and Antibodies for Cancer Therapy

Saved in:
Bibliographic Details
Published inClinical Immunology Vol. 105; no. 3; pp. 233 - 246
Main Authors Helguera, G., Morrison, S.L., Penichet, M.L.
Format Book Review Journal Article
LanguageEnglish
Published San Diego, CA Elsevier Inc 01.12.2002
Elsevier
Subjects
Animals
Antibodies - genetics
Antibodies - therapeutic use
Antineoplastic agents
Biological and medical sciences
Cytokines - genetics
Cytokines - therapeutic use
Immunotherapy
Medical sciences
Mice
Neoplasms, Experimental - blood supply
Neoplasms, Experimental - immunology
Neoplasms, Experimental - therapy
Pharmacology. Drug treatments
Recombinant Fusion Proteins - administration & dosage
Recombinant Fusion Proteins - therapeutic use
Human
interleukin-2
Immune response
Antibody
Cytokine
Interleukin 12
Male
Malignant tumor
interleukin-12
cancer therapy
Treatment
Interleukin 2
Polypeptide
GM-CSF
Immunotherapy
antibody fusion protein
Fusion protein
Granulocyte macrophage colony stimulating factor
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-3
ObjectType-Review-2
ISSN:1521-6616
1521-7035
DOI:10.1006/clim.2002.5302